rine Biomarkers in Cirrhotic Patients with Acute Kidney Injury
Not Applicable
Recruiting
- Conditions
- Acute kidney injuryCirrhosisNovel biomarker
- Registration Number
- TCTR20180905002
- Lead Sponsor
- Rachadapisek Sompot Fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 107
Inclusion Criteria
1. Hospitalized cirrhotic patients with risk of acute kidney injury
Exclusion Criteria
1. Chronic kidney disease or need renal replacement therapy
3. Post renal acute kidney injury or acute glomerulonephritis or acute interstitial nephritis
4. Liver or kidney transplant
5. Need for immunosuppressive drug other than for treatment of severe alcoholic hepatitis
6. Pregnancy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnosis of acute kidney injury by urine LFABP and NGAL compared with serum creatinine Up to 7 days of admission Level of urine LFABP and urine NGAL on the day of acute kidney injury diagnosed by serum creatinine
- Secondary Outcome Measures
Name Time Method Diagnosis of hepatorenal syndrome and acute tubular necrosis by urine LFABP and NGAL Up to 7 days of admission Level of urine LFABP and urine NGAL on the day of hepatorenal syndrome and acute tubular necrosis di